Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2003-10-23
2009-06-30
McIntosh, III, Traviss C (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
07553817
ABSTRACT:
The present invention relates to compositions for supplementing the diet of subjects suffering from cardiovascular or peripheral vascular disease or those at risk for such conditions. Ribose is given alone or in combination with one or a combination of vasodilators, nutrients and vitamins. Preferred vitamins include Vitamins C, B6, B12 and folic acid. Preferred nutrients include glutamine and glucose.
REFERENCES:
patent: 4719201 (1988-01-01), Foker
patent: 4920098 (1990-04-01), Cotter et al.
patent: 6054128 (2000-04-01), Wakat
patent: 6159942 (2000-12-01), St. Cyr et al.
patent: 6172114 (2001-01-01), McCabe
patent: 6218366 (2001-04-01), St. Cyr et al.
patent: 6339716 (2002-01-01), Sawada et al.
patent: 6420342 (2002-07-01), Hageman et al.
patent: 6429198 (2002-08-01), St. Cyr et al.
patent: 02 286620 (1990-11-01), None
Omran et al., “Ribose Improves Myocardial . . . ”, Journal of Molecular and Cellular Cardiology, vol. 33, issue 6, p. A173, Jun. 2001.
Bianco et al., “How congestive heart failure works”, howstuffworks.com.
Omran et al., “Ribose Improves Myocardial . . . ”, Journal of Molecular and Cellular Cardiology, vol. 33, issue 6, p. A173, Jun. 2001.
Cohn, Jay N., MD, Preventing Congestive Heart Failure, American Family Physician, Apr. 15, 1998, vol. 57, Issue 8.
Pliml, W., Effects of Ribose on Exercise-Indusced Ischaemia in Stable Coronary Artery Disease, The Lancet, Aug. 29, 1992: 340(8818), pp. 507-510.
Omran et al., Ribose Improves Myocardial Function and Quality of Life in Congestive Heart Failure Patients, Journal of Molecular and Cellular Cardiology, Jun. 2001, vol. 33, No. 6, pp. A173.
Mahoney, J.R. et al.: “A comparison of Different Compounds . . . ” J. of Surg. Res., vol. 47, 1989, pp. 530-534, Acad. Press, San Diego, CA US.
H.-G. Zimmer et al. “Ribose accelerates . . . ” J. of Mol. & Cel. Cardiol. vol. 16, 1984, pp. 863-866, Acad. Press, :London, UK.
Loscalzo et al. “Nitric oxide . . . ” Progress in Cardiovas. Dis., vol. 38, pp. 87-104, 1995, Saunders, Philadelphia, PA US.
Cyr [sic] et al “Enahnced high energy . . . ” J. of Surg. Res., vol. 46 pp. 157-162, 1989 Acad. Press, San Diego, CA, US.
Pliml, W. et al. “Effects of Ribose . . . ” The Lancet, vol. 340, pp. 507-510, Lancet Limited, London, UK, 1992.
Butler Terri L.
Cyr John St.
Johnson Clarence A.
Bioenergy Inc.
McIntosh, III Traviss C
Terry Kathleen R.
LandOfFree
Methods for improving cardiac function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for improving cardiac function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for improving cardiac function will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4131408